Julia Bohlius receives the Dora Seif Award

      -       English   -  Deutsch  -  Français  -  Italiano
Julia Bohlius receives the Dora Seif Prize for her outstanding contributions in Julia Bohlius receives the Dora Seif Prize for her outstanding contributions in cancer research

Julia Bohlius, Head of Education and Training at Swiss TPH, has been awarded the Dora Seif Cancer Research Prize. She receives this prize for her outstanding contributions to assessing the burden of cancer in people living with HIV, improving the quality of care for women at high risk for cervical cancer, and developing clinical guidelines for oncology interventions.

Every two years, the Basel-based Dora Seif Foundation awards the Dora Seif Cancer Research Prize, worth 5,000 Swiss francs, for the best work that contributes to improving the early detection and treatment (prevention and prophylaxis) of cancer. On December 19, 2022, the Foundation awarded this year’s prize to Julia Bohlius, Head of the Education and Training Department at Swiss TPH, and Walter Weber from the University Hospital Basel.

The award recognizes Julia Bohlius’ outstanding achievements in assessing the cancer burden of people living with HIV, improving the quality of care for women at high risk for cervical cancer, and developing clinical guidelines for oncology interventions. -I am honored to receive this award, and I would like to thank all of the research partners and collaborators who made this research possible," Bohlius said. -I look forward to continuing to advance cancer prevention at the intersection of HIV and health care in disadvantaged populations.

Bohlius, who is also a professor of cancer epidemiology at the University of Basel, applies quantitative methods to her research, using data from cohort studies, cancer registries and data warehouses. In collaboration with the International Agency for Research of Cancer, the Centre for Infectious Disease Research in Zambia and the Cervical Cancer Prevention Program in Zambia, she also leads studies to assess the accuracy of diagnostic tests. In her research, Bohlius is also exploring the use of machine learning and Big Data in collaboration with partners at the National Cancer Registry in South Africa and the University of Bern. With this comprehensive approach, Julia Bohlius aims to draw a differentiated picture of the needs of specific population groups in order to build on this to create innovative guidelines for adapted and thus improved healthcare.